if the FDA is going to pull Synthroid from the market

July 2001

Media reports have patients wondering if the FDA is going to pull Synthroid from the market.

This all started because levothyroxine has been on the market so long...many years before the FDA required New Drug Applications (NDA).

But potency problems have plagued levothyroxine products for years. This has finally prompted the FDA to require ALL levothyroxine products to apply for their own NDA approval.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote